Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.
J AAPOS
; 22(2): 159-161, 2018 04.
Article
em En
| MEDLINE
| ID: mdl-29408337
ABSTRACT
Post-transplant lymphoproliferative disorder (PTLD) has rarely been associated with ocular manifestations. We report a case of bilateral ocular involvement by PTLD with histopathologic features of extranodal marginal zone (MALT) lymphoma in an 8-year-old boy following orthotopic heart transplantation. The anterior segment disease was treated successfully using a combination of intraocular and systemic injections of humanized anti-CD20 antibody (rituximab).
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Complicações Pós-Operatórias
/
Neoplasias da Íris
/
Transplante de Coração
/
Linfoma de Zona Marginal Tipo Células B
/
Rituximab
/
Antineoplásicos Imunológicos
/
Transtornos Linfoproliferativos
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article